Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 4/2010

01-08-2010 | Research Article

An evaluation of consumers’ knowledge, perceptions and attitudes regarding generic medicines in Auckland

Authors: Zaheer-Ud-Din Babar, Joanna Stewart, Shiwangni Reddy, Woroud Alzaher, Prateeka Vareed, Nineweh Yacoub, Bandhana Dhroptee, Anne Rew

Published in: International Journal of Clinical Pharmacy | Issue 4/2010

Login to get access

Abstract

Objectives The aim of this project was to evaluate the perceptions, knowledge and attitudes regarding generic medicines. Methods A cross-sectional study, with self administered questionnaires, was conducted to survey consumers visiting pharmacies in four regions of Auckland (North Shore, Waitakere, Central Auckland and South Auckland). Through stratified random sampling, approximately 10% of pharmacies from each region were selected, which turn out to be 30 pharmacies. Every alternate customer coming to the pharmacy, who was eligible to participate in the study, was asked by the researchers to complete the questionnaire. Results A total of 441 questionnaires were included in the analysis. Different response rates were obtained in different regions of Auckland. Of all respondents, 51.6% had previous knowledge of generic medicines. Pharmacists were the main source of information regarding generic medicines followed by doctors and media. A higher level of education had a direct relationship with having correct knowledge of generics (P = .002). Attitude of participants toward the use of generic medicines was determined by their knowledge of generics, whether it was recommended by a pharmacist and their type of illness. Participants were more prepared to change to a generic for a minor illness (79%) than for a major illness (58.7%). Those who had better knowledge were more likely than those with poor knowledge to say they would to use a generic in major illness (P = .001) as well as minor illness (P < .0001). Previous positive experiences with generics also determined consumers’ willingness to use generics. Conclusion Many consumers have misconceptions regarding generic medicines. Having knowledge about generics and the advice by doctors and pharmacists are key indicators to improve the quality use of generic medicines.
Literature
1.
go back to reference Glover J, Hetzel D, Tennant S. Australia and New Zealand, health systems of international encyclopedia of public health. Oxford: Academic Press; 2008. p. 255–67. Glover J, Hetzel D, Tennant S. Australia and New Zealand, health systems of international encyclopedia of public health. Oxford: Academic Press; 2008. p. 255–67.
4.
go back to reference Williams G, Poynton M. PHARMAC: getting the best bang for your buck since 1993—pharmacy 409 lecture. New Zealand: University of Auckland; 2009. Williams G, Poynton M. PHARMAC: getting the best bang for your buck since 1993—pharmacy 409 lecture. New Zealand: University of Auckland; 2009.
5.
go back to reference Kanavos P. Do generics offer significant savings to the UK National Health Service? Curr Med Res Opin. 2007;23(1):105–16.CrossRefPubMed Kanavos P. Do generics offer significant savings to the UK National Health Service? Curr Med Res Opin. 2007;23(1):105–16.CrossRefPubMed
6.
go back to reference King DR, Kanavos P. Encouraging the use of generic medicines: implications for transition economies. Croat Med J. 2002;43(4):462–9.PubMed King DR, Kanavos P. Encouraging the use of generic medicines: implications for transition economies. Croat Med J. 2002;43(4):462–9.PubMed
7.
go back to reference Meyer MC. United States Food and Drug Administration requirements for approval of generic drug products. J Clin Psychol. 2001;62(5):4–9. Meyer MC. United States Food and Drug Administration requirements for approval of generic drug products. J Clin Psychol. 2001;62(5):4–9.
13.
go back to reference Meredith P. Bioequivalence and other unresolved issues in generic drug substitution. Clin Ther. 2003;25(11):2875–90.CrossRefPubMed Meredith P. Bioequivalence and other unresolved issues in generic drug substitution. Clin Ther. 2003;25(11):2875–90.CrossRefPubMed
16.
go back to reference Borgheini G. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoative drugs. Clin Ther. 2003;25(6):1578–92.CrossRefPubMed Borgheini G. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoative drugs. Clin Ther. 2003;25(6):1578–92.CrossRefPubMed
20.
go back to reference Al-Gedadi NA, Hassali MA, Shafie AA. A pilot survey on perceptions and knowledge of generic medicines among consumers in Penang, Malaysia. Pharm Pract. 2008;6(2):93–7. Al-Gedadi NA, Hassali MA, Shafie AA. A pilot survey on perceptions and knowledge of generic medicines among consumers in Penang, Malaysia. Pharm Pract. 2008;6(2):93–7.
21.
go back to reference Babar ZU, Awaisu A. Evaluating community pharmacists, perception and practices on generic medicines: a pilot study from peninsular Malaysia. J Gen Med. 2008;5:315–30.CrossRef Babar ZU, Awaisu A. Evaluating community pharmacists, perception and practices on generic medicines: a pilot study from peninsular Malaysia. J Gen Med. 2008;5:315–30.CrossRef
24.
go back to reference Latin American conference on economic aspects of essential medicines. World Health Organisation; 1992. Latin American conference on economic aspects of essential medicines. World Health Organisation; 1992.
25.
go back to reference Kjoenniksen I, Lindbaek M, Granas AG. Patients’ attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci. 2006;28(5):284–9.CrossRefPubMed Kjoenniksen I, Lindbaek M, Granas AG. Patients’ attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci. 2006;28(5):284–9.CrossRefPubMed
26.
go back to reference Åstrand B, Hovstadius B, Antonov K, Petersson G. The Swedish national pharmacy register. Stud Health Technol Inform. 2007;129:345–9.PubMed Åstrand B, Hovstadius B, Antonov K, Petersson G. The Swedish national pharmacy register. Stud Health Technol Inform. 2007;129:345–9.PubMed
27.
go back to reference Tolonen H, Helakorpi S, Talala K, Helasoja V, Martelin T, Prättälä R. 25-year trends and socio-demographic differences in response rates: Finnish adult health behaviour survey. Eur J Epidemiol. 2006;21(6):409–15.CrossRefPubMed Tolonen H, Helakorpi S, Talala K, Helasoja V, Martelin T, Prättälä R. 25-year trends and socio-demographic differences in response rates: Finnish adult health behaviour survey. Eur J Epidemiol. 2006;21(6):409–15.CrossRefPubMed
28.
go back to reference Gaither CA, Kirking DM, Ascione FJ, Welage LS. Consumers’ views on generic medications. J Am Pharm Assoc. 2001;41(5):729–36. Gaither CA, Kirking DM, Ascione FJ, Welage LS. Consumers’ views on generic medications. J Am Pharm Assoc. 2001;41(5):729–36.
29.
go back to reference Sansgiry SS, Bhosle M, Pope N. Consumer perceptions regarding generic drug substitution: an exploratory study. J Pharm Mark Manag. 2005;17(1):77–91.CrossRef Sansgiry SS, Bhosle M, Pope N. Consumer perceptions regarding generic drug substitution: an exploratory study. J Pharm Mark Manag. 2005;17(1):77–91.CrossRef
30.
go back to reference Suh DC. Trends of generic substitution in community pharmacies. Pharm World Sci. 1999;21(6):260–5.CrossRefPubMed Suh DC. Trends of generic substitution in community pharmacies. Pharm World Sci. 1999;21(6):260–5.CrossRefPubMed
31.
go back to reference Valles JA, Barreiro M, Cereza G, et al. A prospective multicenter study of the effect of patient education on acceptability of generic prescribing in general practice. Health Policy. 2003;65(3):269–75.CrossRefPubMed Valles JA, Barreiro M, Cereza G, et al. A prospective multicenter study of the effect of patient education on acceptability of generic prescribing in general practice. Health Policy. 2003;65(3):269–75.CrossRefPubMed
32.
go back to reference Heikkilä R, Mäntyselkä P, Hartikainen HK, Ahonen R. Customers’ and physicians’ opinions of and experiences with generic substitution during the first year in Finland. Health Policy. 2007;82(3):366–74.CrossRefPubMed Heikkilä R, Mäntyselkä P, Hartikainen HK, Ahonen R. Customers’ and physicians’ opinions of and experiences with generic substitution during the first year in Finland. Health Policy. 2007;82(3):366–74.CrossRefPubMed
33.
go back to reference Mott DA, Cline RR. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med Care. 2002;40(8):662–74.CrossRefPubMed Mott DA, Cline RR. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med Care. 2002;40(8):662–74.CrossRefPubMed
34.
go back to reference Banahan BF, Kolassa EM. A physician survey on generic drugs and substitution of critical dose medications. Arch Intern Med. 1997;157(18):2080–8.CrossRefPubMed Banahan BF, Kolassa EM. A physician survey on generic drugs and substitution of critical dose medications. Arch Intern Med. 1997;157(18):2080–8.CrossRefPubMed
35.
go back to reference Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for generic prescription drugs. J Am Pharm Assoc (Wash). 2000;40(3):378–83. Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for generic prescription drugs. J Am Pharm Assoc (Wash). 2000;40(3):378–83.
36.
go back to reference Palagyi M, Lassanova M. Patients attitudes towards experience with use of generics in Slovakia, performance of generic substitution. Bratisl Lek Listy. 2008;109(7):324–8.PubMed Palagyi M, Lassanova M. Patients attitudes towards experience with use of generics in Slovakia, performance of generic substitution. Bratisl Lek Listy. 2008;109(7):324–8.PubMed
37.
go back to reference Hassali MA, Kong D, Stewart K. Generic medicines: perceptions of consumers in Melbourne, Australia. Int J Pharm Pract. 2005;13(4):257–64.CrossRef Hassali MA, Kong D, Stewart K. Generic medicines: perceptions of consumers in Melbourne, Australia. Int J Pharm Pract. 2005;13(4):257–64.CrossRef
Metadata
Title
An evaluation of consumers’ knowledge, perceptions and attitudes regarding generic medicines in Auckland
Authors
Zaheer-Ud-Din Babar
Joanna Stewart
Shiwangni Reddy
Woroud Alzaher
Prateeka Vareed
Nineweh Yacoub
Bandhana Dhroptee
Anne Rew
Publication date
01-08-2010
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 4/2010
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-010-9402-0

Other articles of this Issue 4/2010

International Journal of Clinical Pharmacy 4/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.